Clinical Study

Lower Limb Core Scale: A New Application to Evaluate and Compare the Outcomes of Bone and Soft-Tissue Tumours Resection and Reconstruction

Table 5

Scores of the tests for QoL. PCS: physical component summary; MCS: mental component summary (ECOG score range: 0–5; EQ-5D score range: 0-1; EQ-VAS score range: 0–100; SF-36 PCS and SF-36 PCM mean normalized score: 49).

TestECOGEQ-5DEQ-VASSF-36 PCSSF-36 MCS

Total0,98 ± 0,270,73 ± 0,0874,42 ± 6,6141,99 ± 4,350,48 ± 4,47
Males0,77 ± 0,390,82 ± 0,180,59 ± 6,0545,57 ± 5,252,81 ± 4,6
Females1,17 ± 0,380,64 ± 0,1368,52 ± 11,1937,81 ± 6,4447,78 ± 8,04
Age < 55 0,75 ± 0,180,8 ± 0,0676,46 ± 5,4742,33 ± 4,552,16 ± 3,67
Age > 55 1,24 ± 0,340,65 ± 0,1172,1 ± 7,8141,52 ± 4,2348,2 ± 5,45
Proximal site1,22 ± 0,460,68 ± 0,1373,91 ± 8,0641,11 ± 6,5947,41 ± 6,51
Distal site0,73 ± 0,260,77 ± 0,174,95 ± 10,7842,63 ± 5,8552,74 ± 6,04
Malignant lesion0,86 ± 0,280,76 ± 0,0975,14 ± 7,9243,99 ± 4,5450,81 ± 4,73
Benign lesion1,44 ± 0,740,58 ± 0,2371,56 ± 9,9735,33 ± 9,7549,4 ± 12,21
Recurrence0,8 ± 0,390,82 ± 0,1579 ± 17,2742,44 ± 9,7453,22 ± 8,47
Compliance0,93 ± 0,520,71 ± 0,1781,14 ± 9,6541,07 ± 6,7154,95 ± 4,96
Group 10,88 ± 0,440,77 ± 0,1178,13 ± 11,4139,11 ± 6,7952,23 ± 9,36
Group 21 ± 0,320,71 ± 0,173,62 ± 7,6943,39 ± 5,1649,71 ± 4,83